Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yangyin Qingre is a Traditional Chinese Medicine (TCM) herbal intervention based on the therapeutic principle of nourishing yin and clearing heat. It is currently being investigated by Beijing Anding Hospital and Capital Medical University for the treatment of the prodromal phases of bipolar disorder. The treatment aims to address the TCM pathological patterns of yin deficiency and internal heat, which are hypothesized to contribute to the early symptoms and progression of mood disorders. As a botanical combination, it typically involves multiple herbal ingredients administered orally to stabilize mood and improve clinical outcomes in patients at high risk for bipolar episodes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yangyin qingre.